European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes Continuing Medical Education Opportunity

Share Article

Imedex, LLC would like to present the European Focus on Myeloproliferative Neoplasms and Myelodysplatic Syndromes occurring on 4-5 May 2012 in Lisbon, Portugal. This continuing medical education (CME) activity is the first of its kind in Europe and will focus on the latest advances in MPD, MDS and MPN.

Past News Releases

RSS

Imedex, LLC would like to present the European Focus on Myeloproliferative Neoplasms and Myelodysplatic Syndromes occurring on 4-5 May 2012 in Lisbon, Portugal. This continuing medical education (CME) will have a target audience of hematologists, oncologists, and other health-care professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved and/or interested in the therapeutic management of patients with myelodysplastic and myeloproliferative diseases.

This continuing medical education (CME) activity is the first of its kind in Europe and will focus on the latest advances in MPD, MDS and MPN. Attendees of this gastroenterology CME meeting will have the opportunity to network with nationally recognized leaders in the fields of molecular biology, pathology, immunology, and translational and clinical research. The overarching goal of this gastroenterology CME meeting is to present the best new scientific research and advance knowledge in the field. Attendees are encouraged to submit abstracts.

The event promises to be a stimulating, interactive continuing medical education experience for all attendees, who can expect to:

  •     Gain added exposure for their work
  •     Present cutting-edge research that could potentially have a significant impact on patient outcomes and/or management
  •     Provide their colleagues with the opportunity to learn about emerging fields and how they apply to MPD, MDS, and MPN

Upon successful completion of this continuing medical education (CME) activity, participants should additionally be able to:

  •     Develop a greater knowledge of the role of genetic mutations in prognosis and therapeutic decision-making for myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPDs)
  •     Demonstrate an increased confidence in their ability to make risk-stratified treatment decisions for MDS and myelofibrosis (MF)
  •     Better evaluate current treatment options for MDS and MF, including stem cell transplant, chemotherapy, and targeted agents
  •     Have increased confidence in their ability to manage chronic MPNs such as essential thrombocythemia and polycythemia vera
  •     Be more likely to enroll patients in clinical trials of JAK inhibitors and other novel agents for MDS and MPDs

For more information and to register for the European Focus on Myeloproliferative Neoplasm and Myelodysplatic Syndromes on 4-5 May 2012 please contact us:

         E-mail us at registration(at)imedex(dot)com
         Call us toll-free at 1-512-583-8385
         or
         Register Online at http://www.mpnsyndromescongress.com

For event updates, and more information on this exciting oncology-cme event and to connect with us! Find us on:

         Facebook at https://www.facebook.com/pages/Congress-on-Myeloproliferative-Neoplasm-and-Myelodysplastic-Syndromes/281181098572352
         Twitter @MPN_CME

For more Imedex events and updates, visit our blog at http://oncologycme.tumblr.com or go to http://www.imedex.com

Key Terms: Hematology CME, Oncology CME. Gastroenterology CME, Pharmacy CME, Physician Assistant CME, Physicians-in-Training CME, Resident Fellowship CME, Oncology Nurse CE

About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.
Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine. ®

Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at: http://www.audiencegeneration.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Marilyn Holman
Audience Generation
512-708-4678
Email >
Visit website